The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat

Bibliography

• Honkakoski P, Negishi M. Regulation of cytochrome P450 genes by nuclear receptors. Biochem J 2000;347:321-37
   PubMed Web of Science ®Google Scholar
• Hines RN, Luo T, Cresteil T, et al. Molecular regulation of genes encoding xenobiotic-metabolizing enzymes: mechanisms involving endogenous factors. Drug Metab Dispos 2001;29:623-33
   PubMed Web of Science ®Google Scholar
• Wójcikowski J. Potential role of the brain dopaminergic system in the regulation of cytochrome P450 expression. Pol J Pharmacol 2004;56:701-8
   PubMedGoogle Scholar
• Kretschmer XC, Baldwin WS. CAR and PXR: xenosensors of endocrine disrupters? Chem Biol Interact 2005;155:11-128
   Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Duret C, et al. The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu Rev Pharmacol Toxicol 2008;48:1-32
   PubMed Web of Science ®Google Scholar
• Palkovits M, Leranth C, Zaborszky L, Brownstein MJ. Electron microscopic evidence of direct neuronal connection from the lower brain stem to the median eminence. Brain Res 1977;136:339-44
   PubMed Web of Science ®Google Scholar
• Simon H, Le Moal M, Calas A. Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase. Brain Res 1979;178:17-40
   PubMed Web of Science ®Google Scholar
• Oades RD, Halliday GM. Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res Rev 1987;12:117-65
   Web of Science ®Google Scholar
• Conrad LCA, Pfaff DW. Autoradiographic tracing of nucleus accumbens efferents in the rat. Brain Res 1976;133:589-96
   Google Scholar
• Powell EW, Leman RB. Connections of the nucleus accumbens. Brain Res 1976;105:389-403
   PubMed Web of Science ®Google Scholar
• Williams DJ, Crossman AR, Slater P. The efferent projections of the nucleus accumbens in the rat. Brain Res 1977;130:217-27
   PubMed Web of Science ®Google Scholar
• Hokfelt T, Fuxe K, Johansson O, et al. Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur J Pharmacol 1975;134:389-92
   Google Scholar
• Sawchenko PE. Evidence for differential regulation of corticotropin-releasing factor and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related projections of the paraventricular nucleus. Brain Res 1987;437:253-63
   PubMed Web of Science ®Google Scholar
• Sonderfan AJ, Arlotto MP, Dutton DR, et al. Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch Biochem Biophys 1987;255:27-41
   PubMed Web of Science ®Google Scholar
• Waxman DJ. Interactions of hepatic cytochromes P450 with steroid hormones. Biochem Pharmacol 1988;37:71-84
   PubMed Web of Science ®Google Scholar
• Wolterboer HM, De Kruif CA, van Iersel AAJ, et al. Comparison of cytochrome P-450 isoenzyme profiles in rat liver and hepatocyte cultures. Biochem Pharmacol 1991;42:381-90
   PubMed Web of Science ®Google Scholar
• Chinta SJ, Andersen JK. Dopaminergic neurons. Int J Biochem Cell Biol 2005;37:942-6
   PubMed Web of Science ®Google Scholar
• Goudreau JL, Falls WM, Lookingland KJ, Moore KE. Periventricular-hypophysial dopaminergic neurons innervate the intermediate but not the neural lobe of the rat pituitary gland. Neuroendocrinology 1995;62:147-54
   PubMed Web of Science ®Google Scholar
• Seeman P, van Tol HHM. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994;15:264-7
   PubMed Web of Science ®Google Scholar
• Boyson SJ, McGonigle P, Molinoff PB. Quantitative autoradiographic localization of D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci 1986;6:3177-88
   PubMed Web of Science ®Google Scholar
• Meador-Woodruff JH, Mansour A, Healy DJ, et al. Comparison of the distributions of D1 and D2 dopamine receptors mRNAs in rat brain. Neuropsychopharmacology 1991;5:231-42
   PubMed Web of Science ®Google Scholar
• De Souza EB. Serotonin and dopamine receptors in the rat pituitary gland: autoradiographic identification, characterization, and localization. Endocrinology 1986;119:1534-42
   PubMed Web of Science ®Google Scholar
• Wamsley JK, Gehlert DR, Filloux FM, Dawson TM. Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain. J Chem Neuroanat 1989;2:119-37
   PubMed Web of Science ®Google Scholar
• Levant B, Grigoriadis DE, De Souza EB. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. J Pharmacol Exp Ther 1993;264:991-1001
   PubMed Web of Science ®Google Scholar
• Fuller RW, Snoddy HD. Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists. Endocrinology 1981;109:1026-32
   PubMed Web of Science ®Google Scholar
• Jeżova D, Jurcovicova J, Vigas M, et al. Increase in plasma ACTH after dopaminergic stimulation in rats. Psychopharmacology 1985;85:201-3
   PubMed Web of Science ®Google Scholar
• Fuller RW, Snoddy HD, Mason NR, et al. Elevation of serum corticosterone in rats by dopamine agonists related in structure to pergolide. Neuroendocrinology 1983;36:285-90
   PubMed Web of Science ®Google Scholar
• Jeżova D, Vigas M. Apomorphine injection stimulates b-endorphin, adrenocorticotropin, and cortisol release in healthy man. Psychoneuroendocrinology 1988;13:479-85
   PubMed Web of Science ®Google Scholar
• Prough RA, Linder MW, Pinairen JA, et al. Hormonal regulation of hepatic enzymes involved in foreign compound metabolism. FASEB 1996;10:1369-77
   PubMed Web of Science ®Google Scholar
• Quatrochi LC, Guzelian PS. CYP3A regulation: from pharmacology to nuclear receptors. Drug Metab Dispos 2001;29:615-22
   PubMed Web of Science ®Google Scholar
• Lal S, De La Vega C, Sourkes TL, Friesen HG. Effect of apomorphine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone levels in human serum. J Clin Edocrinol Metab 1973;37:719-24
   PubMed Web of Science ®Google Scholar
• Nair NP, Lal S, Iskandar HI, et al. Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion. Brain Res Bull 1982;8:587-91
   PubMed Web of Science ®Google Scholar
• Sherman GP, Kim S, Benjamin F, Kolodny KD. Effect of chlorpromazine on serum growth hormone concentration in man. N Engl J Med 1971;284:72
   PubMed Web of Science ®Google Scholar
• Hanev K, Sasaki A, Yoshinaga K. Evidence for endogenous dopaminergic control of GH release in man. Tohoku J Exp Med 1981;135:103-8
   PubMed Web of Science ®Google Scholar
• Müller EE, Pecile A, Felici M, Cocchi D. Norepinephrine and dopamine injection into lateral brain ventricle of the rat and growth hormone-releasing activity in the hypothalamus and plasma. Endocrinology 1970;86:1376-82
   PubMed Web of Science ®Google Scholar
• Mueller GP, Simpkins J, Meites J, Moore KE. Differential effects of dopamine agonists and haloperidol on the release of prolactin, thyroid stimulating hormone, growth hormone, and luteinizing hormone in rats. Neuroendocrinology 1976;20:121-35
   PubMed Web of Science ®Google Scholar
• Vijayan E, Krulich L, McCann SM. Catecholamic regulation of TSH and growth hormone release in ovariectomized and steroid-primed rats. Neuroendocrinology 1978;26:174-85
   PubMed Web of Science ®Google Scholar
• Onaya T, Hashizume K. Effects of drugs that modify brain biogenic amine concentrations on thyroid activation induced by exposure to cold. Neuroendocrinology 1976;20:47-52
   PubMed Web of Science ®Google Scholar
• Männistö PT, Mattila J, Kaakkola S. Possible involvement of nigrostriatal dopamine system in the inhibition of thyrotropin secretion in the rat. Eur J Pharmacol 1981;76:403-9
   PubMed Web of Science ®Google Scholar
• Morley JE, Brammer GL, Sharp B, et al. Neurotransmitter control of hypothalamic-pituitary-thyroid function in rats. Eur J Pharmacol 1981;70:263-71
   PubMed Web of Science ®Google Scholar
• Schuetz EG, Wrighton SA, Barwick JL, Guzelian PS. Induction of cytochrome P450 by glucocorticoids in rat liver. J Biol Chem 1984;259:1999-2006
   PubMed Web of Science ®Google Scholar
• Monostory K, Kohalmy K, Prough RA, et al. The effect of synthetic glucocorticoid, dexamethasone on CYP1A1 inducibility in adult rat and human hepatocytes. FEBS Lett 2005;579:229-35
   PubMed Web of Science ®Google Scholar
• Vrzal R, Stejskalova L, Monostory K, et al. Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and CYP1A2 expression and activity in primary cultures of human hepatocytes. Chem Biol Interact 2009;179:288-96
   PubMed Web of Science ®Google Scholar
• Bergeron RM, Serron SC, Rinehart JJ, et al. Pituitary component of the aromatic hydrocarbon-mediated expression of CYP2B and CYP2C11. Xenobiotica 1988;28:303-12
   Google Scholar
• Gibson GG, Plant NJ, Swales K, et al. Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man. Xenobiotica 2002;32:165-206
   PubMed Web of Science ®Google Scholar
• Dvorak Z, Modriansky M, Pichard-Garcia L, et al. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9 and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Mol Pharmacol 2003;64:160-9
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Drocourt L, et al. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 2003;1619:243-53
   PubMed Web of Science ®Google Scholar
• Burk O, Wojnowski L. Cytochrome P450 3A and their regulation. Naunyn Schmieebergs Arch Pharmacol 2004;369:105-24
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Drocourt L, et al. Cross-talk between xenobiotic detoxication and other signaling pathways: clinical and toxicological consequences. Xenobiotica 2004;34:633-64
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Drocourt L, Fabre JM, et al. Dexamethasone induces pregnane X receptor and retinoid X receptor-a expression in human hepatocytes: synergistic increaseof CYP3A4 induction by pregnane X receptor. Mol Pharmacol 2000;58:361-72
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Fabre JM, et al. Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 2000;58:1441-50
   PubMed Web of Science ®Google Scholar
• Hukkanen J, Lassila A, Paivarinta K, et al. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 2000;22:360-6
   PubMed Web of Science ®Google Scholar
• Hukkanen J, Vaisanen T, Lassila A, et al. Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells. J Pharmacol Exp Ther 2003;304:745-52
   PubMed Web of Science ®Google Scholar
• Pereira TM, Carlstedt-Duke J, Lechner MC, Gustafsson JA. Identification of a functional glucocorticoid response element in the CYP3A1/igc2 gene. DNA Cell Biol 1998;17:39-49
   PubMed Web of Science ®Google Scholar
• Telhada MB, Pereira TM, Lechner MC. Effect of dexamethasone and Phenobarbital on run-on transcription rate and CYP3A mRNA concentration in rat liver: changes during development. Arch Biochem Biophys 1992;298:715-25
   PubMed Web of Science ®Google Scholar
• Zaphiropoulos PG, Mode A, Norstedt G, Gustafsson JA. Regulation of sexual differentiation in drug and steroid metabolism. TIPS 1989;10:149-53
   PubMed Web of Science ®Google Scholar
• Waxman DJ, Ram PA, Pampori NA, Shapiro BH. Growth hormone regulation of male-specific rat liver P450 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate. Mol Pharmacol 1995;48:790-7
   PubMed Web of Science ®Google Scholar
• Waxman DJ, O'Connor C. Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol 2006;20:2613-29
   PubMed Web of Science ®Google Scholar
• Legraverend C, Mode A, Westin S, et al. Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth hormone secretion. Mol Endocrinol 1992;6:259-66
   PubMed Web of Science ®Google Scholar
• Sundseth SS, Alberta JA, Waxman DJ. Sex-specific, growth hormone-regulated transcription of the cytochrome P450 2C11 and 2C12 genes. J Biol Chem 1992;267:3907-14
   PubMed Web of Science ®Google Scholar
• Pampori NA, Shapiro BH. Feminization of hepatic cytochrome P450s by nominal levels of growth hormone in the feminine plasma profile. Mol Pharmacol 1996;50:1148-56
   PubMed Web of Science ®Google Scholar
• Shimada M, Murayama N, Nagata K, et al. A specific loss of growth hormone abolished sex-dependent expression of hepatic cytochrome P450 in rats: reversal of the profiles by growth hormone-treatment. Arch Biochem Biophys 1997;337:34-42
   PubMed Web of Science ®Google Scholar
• Pampori NA, Agrawal AK, Shapiro BH. Infusion of gender-dependent plasma growth hormone profiles into intact rats: effects of subcutaneous, intraperitoneal, and intravenous routes of rat and human growth hormone on endogenous circulating growth hormone profiles and expression of sexually dimorphic hepatic CYP isoforms. Drug Metab Dispos 2001;29:8-16
   PubMed Web of Science ®Google Scholar
• Schuetz EG, Schuetz JD, May B, Guzelian PS. Regulation of cytochrome P-450b/e and P-450p gene expression by growth hormone in adult rat hepatocytes cultured on a reconstituted basement membrane. J Biol Chem 1990;265:1188-92
   PubMed Web of Science ®Google Scholar
• Liddle C, Mode A, Legraverend C, Gustafsson JA. Constitutive expression and hormonal regulation of male sexually differentiated cytochromes P450 in primary cultured rat hepatocytes. Arch Biochem Biophys 1992;298:159-66
   PubMed Web of Science ®Google Scholar
• Choi HK, Waxman DJ. Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: developmental regulation and role in male-specific liver gene expression. Endocrinology 2000;141:3245-55
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Lee YH. Constitutive expression of hepatic cytochrome P-450 genes. FASEB 1996;10:1112-7
   PubMed Web of Science ®Google Scholar
• Jaffe CA, Turgeon DK, Lown K, et al. Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. Am J Physiol Endocrinol Metab 2002;283:E1008-15
   PubMed Web of Science ®Google Scholar
• Dhir R, Dworakowski W, Tangavel C, Shapiro BH. Sexual dimorphic regulation of hepatic isoforms of human cytochrome P450by growth hormone. J Pharmacol Exp Ther 2006;316:87-94
   PubMed Web of Science ®Google Scholar
• Lamba V, Lamba J, Yasuda K, et al. Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther 2003;307:906-22
   PubMed Web of Science ®Google Scholar
• Swales K, Kakizaki S, Yamamoto Y, et al. Novel CAR-mediated mechanism for synergistic activation of two distinct elements within the human cytochrome P450 2B6 gene in HepG2 cells. J Biol Chem 2005;280:3458-66
   PubMed Web of Science ®Google Scholar
• Devesa J, Barros MG, Gondar M, et al. Regulation of hypothalamic somatostatin by glucocorticoids. J Steroid Biochem Mol Biol 1995;53:277-82
   PubMed Web of Science ®Google Scholar
• Iber H, Chen Q, Sewer M, Morgan ET. Regulation of hepatic cytochrome P450 2C11 by glucocorticoids. Arch Biochem Biophys 1997;343:305-10
   Google Scholar
• Miller TL, Mayo KE. Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. Endocrinology 1997;138:2458-65
   PubMed Web of Science ®Google Scholar
• Ohyama T, Sato M, Ohye H, et al. Effects of adrenalectomy and glucocorticoid receptor antagonist, RU38486, on pituitary growth hormone-releasing hormone receptor gene expression in rats. Peptides 1998;19:1063-7
   PubMed Web of Science ®Google Scholar
• Gehlhaus M, Schmitt N, Volk B, Meyer RP. Antiepileptics drugs affect neuronal androgen signaling via a cytochrome P45-dependent pathway. J Pharmacol Exp Ther 2007;322:550-9
   PubMed Web of Science ®Google Scholar
• Meyer RP, Gehlhaus M, Schwab R, et al. Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment. J Neurochem 2009;109:670-81
   PubMed Web of Science ®Google Scholar
• Yamazoe Y, Murayama N, Shimada M, Kato R. Thyroid hormone suppression of hepatic levels of phenobarbital-inducible P-450b and P-450e, and other neonatal P-450s in hypophysectomized rats. Biochem Biophys Res Commun 1989;160:609-14
   PubMed Web of Science ®Google Scholar
• Waxman DJ, Ram PA, Notani G, et al. Pituitary regulation of the male-specific steroid 6b-hydroxylase P-450 2a (gene product IIIA2) in adult rat liver. Suppressive influence of growth hormone and thyroxine acting at a pretranslational level. Mol Endocrinol 1990;4:447-54
   PubMed Web of Science ®Google Scholar
• Yamazoe Y, Ling X, Murayama N, et al. Modulation of hepatic level of microsomal testosterone 7 alpha-hydroxylase, P-450a (P450IIA), by thyroid hormone and growth hormone in rat liver. J Biochem 1990;108:599-603
   PubMed Web of Science ®Google Scholar
• Liddle C, Goodwin BJ, George J, et al. Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 1998;83:2411-6
   PubMed Web of Science ®Google Scholar
• Ram PA, Waxman DJ. Pretranslational control by thyroid hormone of rat liver steroid 5 alpha-reductase and comparison to the thyroid dependence of two growth hormone-regulated CYP2C mRNAs. J Biol Chem 1990;265:19223-9
   PubMed Web of Science ®Google Scholar
• Basu S, Dasgupta PS. Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 2000;102:113-24
   PubMed Web of Science ®Google Scholar
• Castano A, Herrera AJ, Cano J, Machado A. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J Neurochem 2002;81:150-7
   PubMed Web of Science ®Google Scholar
• Stypula G, Kunert-Radek J, Ste˛pien´ H, et al. Evaluation of interleukins, ACTH, cortisol and prolactin concentration in the blood of patients with Parkinson's disease. Neuroimmunomodulation 1996;3:131-4
   PubMed Web of Science ®Google Scholar
• Ganguli R, Yang ZW, Shurin G, et al. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 1994;51:1-10
   PubMed Web of Science ®Google Scholar
• Maes M, Bosmans E, Calabrese J, et al. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 1995;29:141-52
   PubMed Web of Science ®Google Scholar
• Jankovic BD, Maric D. In vivo modulation of immune system by encephalin. Int J Neurosci 1990;51:167-9
   PubMed Web of Science ®Google Scholar
• Matera L. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 1996;59:599-614
   PubMed Web of Science ®Google Scholar
• Khan ZU, Koulen P, Rubinstein M, et al. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. PNAS 2001;98:1964-9
   PubMed Web of Science ®Google Scholar
• Voltera A, Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 2005;6:626-40
   PubMed Web of Science ®Google Scholar
• Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993;47:169-76
   PubMed Web of Science ®Google Scholar
• Moreau A, Vilarem MJ, Maurel P, Pascussi JM. Xenoreceptors CAR and PXR activation and consequence on lipid metabolism, glucose homeostasis, and inflammatory response. Mol Pharm 2008;5:35-41
   PubMed Web of Science ®Google Scholar
• Warren GW, Poloyac SM, Gary DS, et al. Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration. J Pharmacol Exp Ther 1999;288:945-50
   PubMed Web of Science ®Google Scholar
• Siewert E, Bort R, Kluge R, et al. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology 2000;32:49-55
   PubMed Web of Science ®Google Scholar
• Tinel M, Elkahwaji J, Robin MA, et al. Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes. J Pharmacol Exp Ther 1999;289:649-55
   PubMed Web of Science ®Google Scholar
• Bleu AM, Maurel P, Pichette V, et al. Interleukin-1b, interleukin-6, tumor necrosis factor-a and interferon-g released by viral infection and aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes. Eur J Pharmacol 2003;473:197-206
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Pichard-Garcia L, et al. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem Biophys Res Commun 2000;274:707-13
   PubMed Web of Science ®Google Scholar
• Assenat E, Gerbal-Chaloin S, Larrey D, et al. Interleukin 1b inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 2004;40:951-60
   PubMed Web of Science ®Google Scholar
• Beigneux AP, Moser AH, Shigenaga JK, et al. The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 2000;275:16390-9
   PubMed Web of Science ®Google Scholar
• Fang C, Yoon S, Tinberg N, et al. Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochem Pharmacol 2004;67:1389-97
   PubMed Web of Science ®Google Scholar
• Wójcikowski J, Gołembiowska K, Daniel WA. The regulation of liver cytochrome P450 by the brain dopaminergic system. Curr Drug Metab 2007;8:631-8
   PubMed Web of Science ®Google Scholar
• Wójcikowski J, Daniel WA. Identification of factors mediating the effects of the brain dopaminergic system on the expression of cytochrome P450 in the liver. Pharmacol Rep 2008;60:966-71
   PubMed Web of Science ®Google Scholar
• Wójcikowski J, Gołembiowska K, Daniel WA. Regulation of liver cytochrome P450 by activation of brain dopaminergic system: physiological and pharmacological implications. Biochem Pharmacol 2008;76:258-67
   PubMed Web of Science ®Google Scholar
• Murayama N, Shimada M, Yamazoe Y, Kato R. Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system. Mol Pharmacol 1991;39:811-7
   PubMed Web of Science ®Google Scholar
• Vrzal R, Ulrichova J, Dvorak Z. Aromatic hydrocarbon receptor status in the metabolism of xenobiotics under normal and pathophysiological conditions. Biomed Pap 2004;148:3-10
   PubMedGoogle Scholar
• Sérée E, Villard P-H, Pascussi J-M, et al. Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. Gastroenterology 2004;127:1436-45
   PubMed Web of Science ®Google Scholar
• Hunter J, Kassam A, Winrow CJ, et al. Crosstalk between the thyroid hormone and peroxisome proliferator-activated receptors in regulating peroxisome proliferator-responsive genes. Mol Cell Endocrinol 1996;116:213-21
   PubMed Web of Science ®Google Scholar
• Miller RT, Scappino LA, Long SM, Corton JC. Role of thyroid hormones in hepatic effects of peroxisome proliferators. Toxicol Pathol 2001;29:149-55
   PubMed Web of Science ®Google Scholar
• Baum LO, Strobel HW. Regulation of expression of cytochrome P-450 2D mRNA in rat brain with steroid hormones. Brain Res 1997;765:67-73
   PubMed Web of Science ®Google Scholar
• Rane A, Liu Z, Levol R, et al. Differential effects of neuroleptic agents on hepatic cytochrome P-450 isoenzymes in the male rat. Biochem Biophys Acta 1996;1291:60-6
   PubMed Web of Science ®Google Scholar
• Daniel WA. The influence of the long-term treatment with psychotropic drugs on cytochrome P450: the involvement of different mechanisms. Expert Opin Drug Metab Toxicol 2005;1:203-17
   PubMedGoogle Scholar
• Haduch A, Wójcikowski J, Daniel WA. The activity of cytochrome P450 CYP2B in rat liver during neuroleptic treatment. Pharmacol Rep 2007;59:606-12
   PubMed Web of Science ®Google Scholar
• Murray M. Inhibition and induction of cytochrome P450 2B1 in rat liver by promazine and chlorpromazine. Biochem Pharmacol 1992;44:1219-22
   PubMed Web of Science ®Google Scholar
• Honkakoski P, Jaaskelainen I, Kortelahti M, Urtti A. A novel drug-regulated gene expression system based on the nuclear receptor constitutive androstane receptor (CAR). Pharm Res 2001;18:146-50
   PubMed Web of Science ®Google Scholar
• Cheung C, Yu AM, Chen CS, et al. Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice. J Pharmacol Exp Ther 2006;316:1328-34
   PubMed Web of Science ®Google Scholar
• Meltzer HY. Long-term effects of neuroleptic drugs on the neuroendocrine system. Adv Biochem Psychopharmacol 1985;40:59-68
   PubMedGoogle Scholar
• Kot M, Daniel WA. The brain noradrenergic and serotonergic systems as unknown factors regulating the activity of cytochrome P450. Eur Neuropsychopharmacol 2009;19(Suppl 1):S17
   Web of Science ®Google Scholar